Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
ZYMEWORKS
Acquired Company
Theravance Biopharma
Vancouver
DublinBiotechnologyBiotechnologyHealth CareDescription
Zymeworks Inc. has entered into a definitive agreement to acquire Theravance Biopharma for $17.00 per share in cash, totaling approximately $929 million. In addition to the cash, Theravance shareholders will receive a contingent value right based on future monetization of ampreloxetine. The transaction aims to maximize shareholder value and follows a comprehensive strategic review process.
Fundz sees it the moment ZYMEWORKS makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Theravance Biopharma?
Theravance Biopharma was acquired by ZYMEWORKS, based in Vancouver. The deal was reported on June 29, 2026. Zymeworks Inc. (Nasdaq: ZYME) is a global biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. ZYMEWORKS is publicly traded (ZYME) and operates in Biotechnology.
When did ZYMEWORKS acquire Theravance Biopharma?
ZYMEWORKS's acquisition of Theravance Biopharma was reported on June 29, 2026. Zymeworks Inc. has entered into a definitive agreement to acquire Theravance Biopharma for $17.00 per share in cash, totaling approximately $929 million. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Theravance Biopharma do?
Theravance Biopharma, Inc.'s focus is to deliver Medicines that Make a Difference® in people's lives. It is privately held, operating in Biotechnology, and is based in Dublin.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.